Publications en collaboration avec des chercheurs de Hospital General Universitario de Alicante (31)

2024

  1. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

    Gastric Cancer, Vol. 27, Núm. 4, pp. 747-759

2023

  1. Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study

    United European Gastroenterology Journal, Vol. 11, Núm. 7, pp. 692-699

  2. Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: Results from the EPoS trials

    Gut, Vol. 72, Núm. 5, pp. 951-957

  3. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)

    PLoS Medicine, Vol. 20, Núm. 10

2022

  1. Epigenome-Wide DNA Methylation Profiling of Normal Mucosa Reveals HLA-F Hypermethylation as a Biomarker Candidate for Serrated Polyposis Syndrome

    The Journal of molecular diagnostics : JMD, Vol. 24, Núm. 6, pp. 674-686

2020

  1. Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients

    Biomolecules, Vol. 10, Núm. 1

  2. Variation in Colonoscopy Performance Measures According to Procedure Indication

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 5, pp. 1216-1223.e2

2019

  1. Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 188-201

  2. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome

    Endoscopy, Vol. 51, Núm. 2, pp. 142-151

  3. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

    Clinical and translational gastroenterology, Vol. 10, Núm. 1, pp. e00003

2018

  1. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update

    Gastroenterologia y Hepatologia, Vol. 41, Núm. 9, pp. 585-596

  2. Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial

    United European Gastroenterology Journal, Vol. 6, Núm. 10, pp. 1527-1537

  3. Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox

    United European Gastroenterology Journal, Vol. 6, Núm. 4, pp. 622-629

  4. Plasma miRNAs signature validation for early detection of colorectal cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106

  5. Short article: Endoscopic ultrasound-guided fine-needle aspiration of portal vein thrombosis in patients with chronic liver disease and suspicion of hepatocellular carcinoma

    European Journal of Gastroenterology and Hepatology, Vol. 30, Núm. 4, pp. 418-423

2017

  1. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs

    United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260

2016

  1. Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study

    Gut, Vol. 65, Núm. 11, pp. 1829-1837

  2. Endoscopist characteristics that influence the quality of colonoscopy

    Endoscopy, Vol. 48, Núm. 3, pp. 241-247

  3. Rationale and design of the European Polyp Surveillance (EPoS) trials

    Endoscopy, Vol. 48, Núm. 6, pp. 571-578

2014

  1. Effect of oral anticoagulants on the outcome of faecal immunochemical test

    British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337